Healthcare
Live Price
Offline$0.635
+0.63% today
1Y Change
-28.99%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
VYNE Therapeutics Inc. (VYNE) is a Healthcare stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $0.63 and down 29.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +13.8%, EPS growth of +34.0%, a dividend yield of 0.0%. What stands out right now is revenue +13.8%, EPS +34.0%, free cash flow +2.8% with operating margin -5219.1% and ROIC -107.1%. Valuation already assumes a fairly strong business story at price/sales 19.2. Stock Foundry combines VYNE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VYNE
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VYNE Max Drawdown
-83.79%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VYNE and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.